» Articles » PMID: 34964688

Uterine Fibroids: Hiding in Plain Sight

Overview
Specialty Physiology
Date 2021 Dec 29
PMID 34964688
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Uterine fibroids (leiomyomas) are present in >75% of women and can cause serious morbidity. They are by far the leading cause of hysterectomy. Fibroids are a complex mixture of cells that include fibroblasts and smooth muscle cells. Rich in extracellular matrix, they typically arise through somatic mutations, most commonly . Their lack of growth inhibition and their ability to have facets of malignancy yet be histologically and biologically benign provide opportunities to explore basic processes. To date, the mechanisms responsible for growth and development of leiomyomas are an enigma. This review provides an overview of current understanding and future directions for clinical and basic research of fibroids.

Citing Articles

Detection of exon2-MED12 mutations in uterine leiomyomas from Syrian patients.

Albitar L, Al-Chatty E, Ahmad F Sci Rep. 2025; 15(1):452.

PMID: 39747270 PMC: 11697450. DOI: 10.1038/s41598-024-84439-4.


Evaluation of the In Vivo Efficacy of the JAK Inhibitor AZD1480 in Uterine Leiomyomas Using a Patient-derived Xenograft Murine Model.

Neblett 2nd M, Ducharme M, Meridew J, Haak A, Girard S, Tschumperlin D Reprod Sci. 2024; 32(2):417-427.

PMID: 39738934 DOI: 10.1007/s43032-024-01775-6.


Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials.

Simon J, Stewart E, Jewell S, Li M, Snabes M F S Rep. 2024; 5(3):285-295.

PMID: 39381651 PMC: 11456625. DOI: 10.1016/j.xfre.2024.06.002.


Novel insights into post-marketing AEs associated with leuprorelin: A comprehensive analysis utilizing the FAERS database.

Han H, Bu X, Wang X, Chen S, Tian N, Jin J Heliyon. 2024; 10(15):e34969.

PMID: 39157412 PMC: 11327563. DOI: 10.1016/j.heliyon.2024.e34969.


Uterine fibroids in women diagnosed with acromegaly: a systematic review.

Gorski K, Zgliczynski S, Stelmachowska-Banas M, Czajka-Oraniec I, Zgliczynski W, Ciebiera M Rev Endocr Metab Disord. 2024; 25(4):773-781.

PMID: 38668933 PMC: 11294406. DOI: 10.1007/s11154-024-09883-z.


References
1.
Kim H, Kim S, Oh Y, Heo S, Kim K, Kim D . Effects of Phthalate Esters on Human Myometrial and Fibroid Cells: Cell Culture and NOD-SCID Mouse Data. Reprod Sci. 2020; 28(2):479-487. DOI: 10.1007/s43032-020-00341-0. View

2.
Sengoba K, Ghant M, Okeigwe I, Mendoza G, Marsh E . Racial/Ethnic Differences in Women's Experiences with Symptomatic Uterine Fibroids: a Qualitative Assessment. J Racial Ethn Health Disparities. 2016; 4(2):178-183. PMC: 5064808. DOI: 10.1007/s40615-016-0216-1. View

3.
Gore A, Chappell V, Fenton S, Flaws J, Nadal A, Prins G . EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015; 36(6):E1-E150. PMC: 4702494. DOI: 10.1210/er.2015-1010. View

4.
Shen Y, Dong Y, Lu Q, Xu J, Wu Y, Yun S . Phenolic environmental estrogens in urine and blood plasma from women with uterine leiomyoma: Epidemiological survey. J Obstet Gynaecol Res. 2016; 42(4):440-5. DOI: 10.1111/jog.12928. View

5.
Ilha M, Newman S, van Amstel S, Fecteau K, Rohrbach B . Uterine lesions in 32 female miniature pet pigs. Vet Pathol. 2010; 47(6):1071-5. DOI: 10.1177/0300985810382522. View